Hermitage Hotel Prague, Prague, Czech Republic
26 - 27 June 2026
Professional Workshop
The International Hyperoxaluria Workshop is recognized globally as the largest professional event in which leading stakeholders come together to explore clinical advances, cultural trends, and current research outcomes that will inform our work and provide better care to those facing the challenges of hyperoxaluria diseases.
Collaboratively, leading experts, researchers, clinicians, and members of industry will engage each other through inspiring dialogue aiming to advance the highest quality and development of hyperoxaluria future outcomes.
All conference registrations will include full access to the 2-day scientific program, access to the poster exhibition and networking events.
ACCOMMODATION
DOWNLOADS
Access key conference documents and resources, including the Abstract Book and Practical Information Guide.
ABSTRACT BOOK
View / Download the complete Abstract Book of the IHW 2026
PRACTICAL INFORMATION
View / Download the complete Practical Information
CONTACTS
If you have any questions or need assistance, please contact us using the appropriate email address on the right.
REGISTRATION
For inquiries about the registration: registration.ihw2026@c-in.eu
PROGRAM
For inquiries about the program: abstracts.ihw2026@c-in.eu
Key Dates
- Abstract Submission Deadline: 15 April 2026 (closed)
- Travel Grant Application Deadline: 15 April 2026 (closed)
- Notification Letters for the Authors: 30 April 2026
- Accommodation Booking Deadline: 10 May 2026
- Standard Registration Deadline: 13 May 2026
Accommodation
Workshop Leadership
Conference Directors
Yaacov Frishberg, MD
Shaare Zedek Medical Center
Jerusalem, Israel
Steering Committee
Nicola Brunetti Pierri, MD
University of Naples
Naples, Italy
Monica Diaz-Gavilan, PhD
University of Granada
Granada, Spain
Sonia Fargue, MD, PhD
University of Alabama at Birmingham
Birmingham, Alabama, USA
Ita Pfeferman Heilberg, M.D., PhD.
Federal University of São Paulo
Sao Paulo, Brazil
Mathieu Lemaire, MSc MDCM PhD FRCP(C)
The Hospital for Sick Children
University of Toronto
Toronto, Canada
Mini Michael, MD, FRACP, FASN, MMed
Texas Children’s Hospital
Houston, Texas, USA
Shabbir Moochhala, MBChB, PhD, FRCPE
Royal Free Hospital
London, UK
Eduardo Salido, MD, PhD
University Hospital of Canary Islands
Tenerife, Spain
Neveen Soliman, MD, PhD
Cairo University
Cairo, Egypt
Bhaskar Somani, MRCS, FEBU, FRCS
University Hospital Southampton
Southampton, UK
Velibor Tasic, MD, PhD, FESPN
University Children’s Hospital
Skopje, Macedonia
Jakub Zieg, MD, PhD
University Motol Hospital
Prague, Czech Republic
Presenting Sponsor
Breakthrough Sponsors
Conference Directors
|
Yaacov Frishberg, MD Shaare Zedek Medical Center Jerusalem, Israel |
Kyle D. Wood, MD University of Alabama at Birmingham Birmingham, Alabama |
Steering Committee
| Yaacov Frishberg, M.D. Shaare Zedek Medical Center Jerusalem, Israel |
Jaap Groothoff, M.D. Emma Children’s Hospital Amsterdam, Netherlands |
Peter C. Harris, Ph.D. Mayo Clinic Rochester, MN, United States |
Felix Knauf, M.D. Charité – University Medicine Berlin, Germany |
| John Knight, Ph.D. University of Alabama at Birmingham Birmingham, AL, United States |
W. Todd Lowther, Ph.D. Wake Forest School of Medicine Winston-Salem, NC, United States |
Shabbir Moochhala, M.D. Royal Free Hospital London, United Kingdom |
Lama Nazzal, M.D., MSc. New York University New York, NY, United States |
| Gregory Tasian, M.D., MSc, MSCE The Children’s Hospital of Philadelphia Philadelphia, PA, United States |
Jonathan Whittamore, Ph.D. University of Texas Southwestern Dallas, TX, United States |
Call for Abstracts
The scientific committee of the 15th International Hyperoxaluria Workshop invites all to submit an abstract on the following program topics. Each session will be comprised of clinical updates, major challenges, and a research update. There is a 300-word limit.
- Oxalate Metabolism
- Oxalate-Induced Disease Outside the Kidneys
- PH3 – The Most Prevalent and Mysterious Form of PH
- Current Treatment of PH1
- Future Therapeutic Approaches for PH
- Extra-Hepatic Oxalate Production
- Making PH Care Work in Resource-Poor Settings
- Enteric Hyperoxaluria
- Urology
- Hyperoxaluria Registries / Centers
Deadline for general abstract submission April 1st, 2026 and notifications will be received by April 15th, 2026.
Young Investigator Travel Grants
Sponsorship
Your sponsorship helps us to empower and educate patients, advocates, and hyperoxaluria disease stakeholders to help them drive progress and create positive change. The International Hyperoxaluria Workshop offers many unique opportunities to support the OHF community by participating in the largest think tank event for the Hyperoxaluria community. We welcome the support of our sponsors and partners in raising awareness and helping to equip patients, advocates, physicians, and researchers with information, tools, and insights that will prepare them for the road ahead.
- Drive research
- Promote innovation
- Lead to breakthroughs
- Change lives
If you are interested in sponsoring the workshop, or would like more information, please contact Julie Bertarelli at julieb@ohf.org.
Workshop Sponsors
Champion Level
Alnylam has funded the scientific, medical, and educational part of the meeting only.
Friend Level
